HIV-associated dementia, a consequence of advanced HIV infection, shares commonalities with Alzheimer's disease and other forms of dementia. Both conditions manifest through cognitive decline, memory loss, and behavioral changes. However, HIV-associated dementia typically emerges in the later stages of untreated HIV/AIDS when the virus affects the brain. In contrast, Alzheimer's disease involves progressive neurodegeneration unrelated to HIV infection. Effective antiretroviral therapy (ART) has significantly reduced the occurrence of HIV-associated dementia. Unlike Alzheimer's, which predominantly affects older adults, HIV-associated dementia can impact younger populations when HIV is untreated, emphasizing the critical role of early diagnosis and treatment in managing cognitive complications linked to HIV/AIDS.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States